Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | ATM | Q13315 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL956091 | 1.00 | CYP1A2 (0.63) | CYP1A2CYP2C19TNFRSF1AMAPTALDH1A1 | |
| SCHEMBL6989990 | 0.86 | TNFRSF1A (0.72) | CYP1A2CYP2C19TNFRSF1AMAPTALDH1A1 | |
| SCHEMBL6989989 | 0.86 | TNFRSF1A (0.72) | CYP1A2CYP2C19TNFRSF1AMAPTALDH1A1 | |
| SCHEMBL11480420 | 0.82 | MAPT (0.59) | CYP1A2CYP2C19TNFRSF1AMAPTSMN1; SMN2 | |
| SCHEMBL28024599 | 0.80 | TNFRSF1A (0.64) | CYP1A2CYP2C19TNFRSF1AMAPTSMN1; SMN2 | |
| SCHEMBL6451968 | 0.80 | TNFRSF1A (0.64) | CYP1A2CYP2C19TNFRSF1AMAPTSMN1; SMN2 | |
| SCHEMBL11818127 | 0.80 | ALDH1A1 (0.78) | MAPTALDH1A1SMN1; SMN2ATMPKM | |
| SCHEMBL5854010 | 0.80 | MAPT (0.63) | CYP1A2CYP2C19MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL11587157 | 0.80 | MAPT (0.63) | CYP1A2CYP2C19MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL10694907 | 0.80 | ALDH1A1 (0.52) | CYP1A2CYP2C19TNFRSF1AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114426564-B | Chiral ferrocene phosphine-1, 2-diphenyl ethylenediamine ligand and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2023-09-08 | — | — | CN | disclosed |
| CN-114426564-A | Chiral ferrocenyl phosphine-1, 2-diphenyl ethylene diamine ligand and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2022-05-03 | — | — | CN | disclosed |
| EP-2183228-B1 | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS INC (US) | 2014-08-20 | — | — | EP | disclosed |
| US-8575156-B2 | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 | VITAE PHARMACEUTICALS, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| CN-102924710-A | Polyaryletherketone resin with carbazole ring in main chain and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2013-02-13 | — | — | CN | disclosed |
| US-20110015157-A1 | CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | Vitae Pharmaceuticals ,Inc. | 2011-01-20 | — | — | US | disclosed |
| EP-2183228-A1 | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 | Vitae Pharmaceuticals, Inc. (US) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009017664-A1 | CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2006089038-A2 | INSECTICIDAL TETRAHYDROINDENOPYRIDINE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015157-A1 | CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | HSD11B1, HSD11B2, HSD3B1 | CYP1A2 120/4885CYP2C19 175/4885TNFRSF1A 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.